Abstract
The operation of anterior resection with total mesorectal excision (TME) has become the gold standard for the treatment of cancer of the rectum, except where the tumour is close to or involving the anal sphincter complex. The reason for this relates to the low incidence of local recurrence after this procedure, which has now been reported by several independent groups.1-3 Although controversy still exists around the role of TME in tumours of the upper rectum, it is now widely accepted for tumours of the middle and lower third.4
| Original language | English |
|---|---|
| Pages (from-to) | 40-5 |
| Number of pages | 6 |
| Journal | Journal of the Royal College of Surgeons of Edinburgh |
| Volume | 44 |
| Issue number | 1 |
| Publication status | Published - Feb 1999 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anastomosis, Surgical
- Colon
- Humans
- Ileostomy
- Postoperative Complications
- Preoperative Care
- Rectal Neoplasms
- Rectum
- Surgical Procedures, Operative
Fingerprint
Dive into the research topics of 'Anterior resection with total mesorectal excision'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver